Pharmacokinetics of etoposide with intravenous drug administration in children and adolescents
Authors:
- 1 February 2003
- journal article
- research article
- Published by Wiley in Pediatrics International
- Vol. 45 (1) , 74-79
Abstract
Background : Pharmacokinetics of etoposide in Japanese children and adolescents has not been investigated. The objectives of the present study were (i) to document the pharmacokinetics of etoposide in Japanese children; (ii) to determine the intra‐ and interpatient variability in systemic etoposide exposure and (iii) to obtain insights into the age–pharmacokinetic parameter relationship. Methods : Pharmacokinetic studies of etoposide, given at doses of 60–200 mg/m2 by intravenous (i.v.) route of administration, were conducted in 18 children and adolescents (aged Results : Pharmacokinetic parameters (mean~SD) of the 14 patients (24 courses) who received etoposide 100 mg/m2 were as follows: peak serum concentration (Cmax), 18.5~6.4 μg/mL; trough serum concentration, 0.2~0.1 μg/mL; biological half‐life (T1/2), 3.6~0.7 h; volume of distribution (Vd), 6.3~3.4 L/m2; area under the etoposide serum concentration‐time curve (AUC), 129~38 hr•μg/mL; systemic clearance, 21.1~10.8 mL/min per m2. The T1/2, Vd, and AUC were not associated with age. An increase in etoposide dose per body surface area (BSA) was associated with increase in its Cmax and area under the time‐concentration curve (AUC). Wide interpatient variability in these parameters was demonstrated. Conclusion : The present study demonstrated that: (i) Pharmacokinetics of etoposide in Japanese children and adolescents were similar to those in Caucasians. (ii) Increased exposure to etoposide was associated with the Cmax. A clear correlation between Cmax and AUC was also found. (iii) Selecting the dose of etoposide according to body surface area (BSA) might give an acceptable range of exposure for children more than 1 year of age.Keywords
This publication has 8 references indexed in Scilit:
- A study of the feasibility and accuracy of pharmacokinetically guided etoposide dosing in childrenBritish Journal of Cancer, 1998
- Etoposide achieves potentially cytotoxic concentrations in CSF of children with acute lymphoblastic leukemia.Journal of Clinical Oncology, 1996
- Steady-state levels and bone marrow toxicity of etoposide in children and infants: does etoposide require age-dependent dose calculation?Journal of Clinical Oncology, 1995
- A randomized trial of two etoposide schedules in small-cell lung cancer: the influence of pharmacokinetics on efficacy and toxicity.Journal of Clinical Oncology, 1994
- Clinical pharmacodynamics of continuous-infusion etoposideCancer Chemotherapy and Pharmacology, 1990
- High-performance liquid chromatography of etoposide in plasma and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Pharmacokinetics of teniposide (VM26) and etoposide (VP16-213) in children with cancerCancer Chemotherapy and Pharmacology, 1982
- Pharmacokinetics of VP16-213 given by different administration methodsCancer Chemotherapy and Pharmacology, 1982